Christian Vasquez

All filings by Christian Vasquez on record concern BioAtla, Inc., in the capacity of chief executive. In total, 54 filings cover trades dated from 14 June 2021 to 31 May 2026.

The open-market side counts 5 purchases for €199k alongside 15 sales for €112k. The net balance comes to €88k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 33 share grants.

Half of the purchases are above €40k and half below. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 5 June 2026 with a share grant (€277) in BioAtla, Inc. The latest purchase dates back some time: it was published 1,056 days ago, on 19 December 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.